Scarica l'app Stockscreener
6.73
7.00%
0.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Novavax Inc Borsa (NVAX) Ultime notizie
FDA approves Novavax COVID-19 shot but with unusual restrictions - NBC 6 South Florida
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk - News Channel 3-12
FDA approves Novavax COVID vaccine with new conditions - Reuters
FDA Approves Novavax COVID-19 Shot But With Unusual Restrictions - Barchart.com
Novavax COVID-19 vaccine approved by the FDA - MSN
FDA Approves Novavax's COVID-19 Vaccine, Paving Way for Milestone Payment - GuruFocus
F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions - The New York Times
Novavax wins narrowed approval for its Covid-19 shot after delay - statnews.com
When the Price of (NVAX) Talks, People Listen - news.stocktradersdaily.com
Novavax (NasdaqGS:NVAX) Reports Q1 2025 Financial Turnaround - Yahoo Finance
Novavax (NVAX) Awaits New FDA Vaccine Regulatory Framework - GuruFocus
HHS to stop recommending Covid shots for children, pregnant women, WSJ reports - marketscreener.com
FDA to issue new vaccine framework within weeks (PFE:NYSE) - Seeking Alpha
Novavax rises after massive Q1 beat, guidance raise - MSN
Novavax set to snap six days of losses as shares trade in green - MSN
Novavax at BofA Securities: Strategic Growth and Partnerships - Investing.com Australia
Novavax at BofA Securities: Strategic Growth and Partnerships By Investing.com - Investing.com UK
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax projects $1.025B 2025 revenue framework with focus on partnerships - MSN
Novavax: Initiating Hold Rating After Strong, But Misunderstood Q1 2025 Earnings Beat - Seeking Alpha
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Ra - GuruFocus
Novavax First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Benzinga Bulls And Bears: IBM, Novavax, Arm Holdings — And UK Trade Deal Boosts Markets - Benzinga
JP Morgan Lowers Price Target for NVAX, Maintains Underweight Rating | NVAX Stock News - GuruFocus
Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up - Yahoo Finance
Analysts Just Shipped An Incredible Upgrade To Their Novavax, Inc. (NASDAQ:NVAX) Estimates - Yahoo Finance
Novavax (NVAX) Faces Price Target Cut Amid Regulatory Concerns | NVAX Stock News - GuruFocus
Novavax: Q1 Earnings Snapshot - New Haven Register
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... - Yahoo Finance
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Sur - GuruFocus
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships and Challenges - GuruFocus
Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... By GuruFocus - Investing.com Canada
Decoding Novavax Inc (NVAX): A Strategic SWOT Insight - GuruFocus
Novavax (NVAX) Sets Sights on Profitability with Strategic Shifts - GuruFocus
Novavax (NVAX) Shares Surge After Upbeat Q1 Results and Raised R - GuruFocus
Novavax says talks with FDA on COVID vaccine approval ongoing calming investor fears - Reuters
Health Care Stocks See Mixed Results In Market Movements - Finimize
Novavax (NVAX) Eyes Resolution with FDA for Covid Vaccine Approval | NVAX Stock News - GuruFocus
Why This Shrinking Covid-19 Vaccine Stock Jumped 30% - Barron's
COVID Vaccine Maker Novavax Stock Soars 16%Here's Why - Yahoo Finance
Novavax Q1 2025 slides: Revenue surges to $667M, company raises full-year guidance By Investing.com - Investing.com South Africa
Novavax (NVAX) Set to Release Q1 Earnings with Strong Revenue Gr - GuruFocus
FDA advisory panel to discuss makeup of updated COVID shots - Seeking Alpha
Novavax Hauls in $666M Q1 Windfall, Boosts FY25 Outlook - Yahoo Finance
Thursday's Top 5 Trending Stocks: What's Going On With D-Wave, Novavax, Carvana? - Benzinga
1.54%
7.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):